133 related articles for article (PubMed ID: 6429988)
1. Somatomedin A increments are diminished in acromegaly with concomitant hyperprolactinaemia.
Hulting AL; Hall K; Werner S
Acta Endocrinol (Copenh); 1984 Jul; 106(3):305-10. PubMed ID: 6429988
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone producing pituitary adenomas with concomitant hypersecretion of prolactin are particularly sensitive to photon irradiation.
Werner S; af Trampe E; Palacios P; Lax I; Hall K
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1713-20. PubMed ID: 4030438
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
[TBL] [Abstract][Full Text] [Related]
4. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
Edén S; Bengtsson BA; Albertsson-Wikland K; Elfversson J; Lindstedt G; Lundberg PA; Petruson B; Rosberg S
Acta Endocrinol (Copenh); 1989 Jan; 120(1):113-20. PubMed ID: 2492135
[TBL] [Abstract][Full Text] [Related]
5. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.
Franks S; Jacobs HS; Nabarro JD
Clin Endocrinol (Oxf); 1976 Jan; 5(1):63-9. PubMed ID: 813917
[TBL] [Abstract][Full Text] [Related]
6. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
8. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
9. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
10. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
11. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
Van Vliet G; Bosson D; Robyn C; Craen M; Malvaux P; Vanderschueren-Lodeweyckx M; Wolter R
Horm Res; 1985; 22(1-2):32-45. PubMed ID: 3928475
[TBL] [Abstract][Full Text] [Related]
12. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
[TBL] [Abstract][Full Text] [Related]
13. Prolactin secretion in acromegalic patients before and after selective adenomectomy.
Tsuchiya H; Onishi T; Takamoto S; Imanaka S; Saitoh Y; Mogami H; Mori S; Uozumi T; Kumahara Y
J Clin Endocrinol Metab; 1985 Jul; 61(1):104-9. PubMed ID: 3923026
[TBL] [Abstract][Full Text] [Related]
14. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
Ciccarelli E; Grottoli S; Razzore P; Gianotti L; Arvat E; Deghenghi R; Camanni G; Ghigo E
Clin Endocrinol (Oxf); 1996 Jan; 44(1):67-71. PubMed ID: 8706295
[TBL] [Abstract][Full Text] [Related]
15. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
16. Criteria for the cure of acromegaly: comparison between basal growth hormone and somatomedin C plasma concentrations in active and non-active acromegalic patients.
Giannella-Neto D; Wajchenberg BL; Mendonça BB; Almeida SF; Macchione M; Spencer EM
J Endocrinol Invest; 1988 Jan; 11(1):57-60. PubMed ID: 3361077
[TBL] [Abstract][Full Text] [Related]
17. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
[TBL] [Abstract][Full Text] [Related]
18. Plasma growth hormone responses to sulpiride in patients with acromegaly.
Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
[TBL] [Abstract][Full Text] [Related]
19. Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.
Hoyte KM; Martin JB
J Clin Endocrinol Metab; 1975 Oct; 41(4):656-9. PubMed ID: 809457
[TBL] [Abstract][Full Text] [Related]
20. Normal growth hormone secretion is rare after microsurgical normalization of growth hormone levels in acromegaly.
Hulting AL; Werner S; Wersäll J; Tribukait B; Anniko M
Acta Med Scand; 1982; 212(6):401-5. PubMed ID: 6818841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
